Фоновий візерунок
Зображення ліків

Citalopram cinfa 20 mg comprimidos recubiertos con pelÍcula efg

Про препарат

Introduction

Leaflet: information for the user

Citalopram cinfa 20 mg film-coated tablets

Read this leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only; do not give it to others even if they have the same symptoms as you, as it may harm them.
  • If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contentsof the leaflet

  1. What Citalopram cinfa is and what it is used for.
  2. What you need to know before you start taking Citalopram cinfa.
  3. How to take Citalopram cinfa.
  4. Possible side effects.
  5. Storage of Citalopram cinfa.
  6. Contents of the pack and additional information.

1. What is Citalopram cinfa and what is it used for

Citalopram cinfa is a selective serotonin reuptake inhibitor (SSRI) and belongs to a group of medicines known as antidepressants. These medicines help correct certain chemical imbalances in the brain that cause symptoms of your illness.

Citalopram cinfa is indicated for the treatment of:

  • Depression and prevention of relapses and recurrences.
  • Anxiety disorder with or without agoraphobia.
  • Obsessive-compulsive disorder (OCD).

Your doctor may, however, prescribe this medicine for any other purpose. Ask your doctor if you have any doubts as to why they have prescribed Citalopram cinfa.

2. What you need to know before starting to take Citalopram cinfa

Do not take Citalopram cinfa

  • If you are allergic to citalopram or any of the other ingredients of this medicine (listed in section 6).
  • If you are taking other medicines that belong to a group called monoamine oxidase inhibitors (MAOIs). MAOIs include medicines such as phenelzine iproniazid, isocarboxazid, nialamide, tranylcypromine, selegiline (used in the treatment of Parkinson's disease), moclobemide (used for the treatment of depression), and linezolid (an antibiotic).
  • If you have any type of heart rhythm disorder from birth or have ever had an episode of this type (this is observed with an electrocardiogram, a test that evaluates how the heart works).
  • If you are taking medicines because you have a disease that alters the heart rhythm.
  • If you are taking medicines that can affect the heart rhythm.

Also see the section “Taking Citalopram cinfa with other medicines” below.

Even if you have finished treatment with MAOIs, you will need to wait 2 weeks before starting your treatment with citalopram.

You must wait a day after taking moclobemide.

After finishing citalopram, you must wait a week before taking any MAOI.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Citalopram cinfa:

Please inform your doctor if you have any other condition or disease since your doctor may need to take it into account.In particular, inform your doctor:

  • If you have manic episodes or anxiety disorder.
  • If you have liver or kidney failure. Your doctor may need to adjust the dose.
  • If you have diabetes. The treatment with citalopram may alter blood sugar control. You may need to adjust the dose of insulin and/or oral hypoglycemic agents.
  • If you have epilepsy. Treatment with citalopram should be discontinued if seizures occur or if there is an increase in seizure frequency (see also section 4 “Possible side effects”).
  • If you have a history of bleeding disorders or if you develop unusual bleeding or bruising, or if you are pregnant (see “Pregnancy, breastfeeding, and fertility”).
  • If you have low sodium levels in the blood.
  • If you are receiving electroconvulsive therapy.
  • If you have or have had any heart problems or have recently had a heart attack.
  • If, when at rest, your heart beats slowly (this is known as bradycardia) and/or you think your body may be losing salt, for example, because you have had diarrhea and vomiting for several days or because you have taken diuretics (medicines to urinate).
  • If you have noticed that your heartbeats are rapid or irregular or have had fainting or dizziness when getting up from a sitting or lying position. This could indicate that you have a heart rhythm disorder.
  • If you have or have had eye problems in the past, such as certain types of glaucoma (increased pressure in the eye).

Consult your doctor, even if any of the circumstances mentioned above have occurred at any time.

Some patients with manic-depressive illness may enter a manic phase. This is characterized by unusual and rapid changes in ideas, excessive joy, and excessive physical activity. If you experience this, contact your doctor.

Symptoms such as restlessness or difficulty sitting or staying upright (akathisia) may also occur during the first weeks of treatment. Inform your doctor immediately if you experience these symptoms.

Some medicines in the group to which citalopram belongs (called SSRIs/SNRIs) may cause sexual dysfunction symptoms (see section 4). In some cases, these symptoms persist after stopping treatment.

Special information related to your disease

Like other medicines used to treat depression or related diseases, improvement does not occur immediately. After starting treatment with Citalopram cinfa, it may take several weeks before you experience any improvement.

In the treatment of anxiety disorder, it usually takes 2-4 weeks before any improvement is observed.

At the beginning of treatment, some patients may experience an increase in anxiety, which will disappear with continued treatment. Therefore, it is very important that you follow your doctor's instructions exactly and do not interrupt or change the dose without consulting your doctor.

Thoughts of suicide and worsening of your depression or anxiety disorder

If you are depressed and/or have an anxiety disorder, you may occasionally have thoughts of harming yourself or taking your life. These may increase when taking antidepressants for the first time, as all these medicines require time to start working, usually around 2 weeks, although in some cases it may take longer.

You would be more prone to having these thoughts:

  • If you have previously had thoughts of harming yourself or taking your life.
  • If you are ayoung adult. Information from clinical trials has shown an increased risk of suicidal behavior in young adults (under 25 years) with psychiatric diseases who were treated with an antidepressant.

If you ever have thoughts of harming yourself or taking your life,contact your doctor or go directly to a hospital.

It may be helpful for you to tell a family member or close friendthat you are depressed or have an anxiety disorder and ask them to read this leaflet. You can ask them if they think your depression or anxiety disorder has worsened, or if they are concerned about changes in your attitude.

Children and adolescents

Citalopram should not normally be used in the treatment of children and adolescents under 18 years old. At the same time, you should know that in patients under 18 years old, there is a higher risk of adverse effects such as suicidal attempts, suicidal thoughts, and hostility (mainly aggression, confrontational behavior, and irritability) when taking this type of medicine. However, the doctor who prescribes it may prescribe citalopram to patients under 18 years old when they decide it is best for the patient. If the doctor who prescribes it has prescribed citalopram to a patient under 18 years old and wants to discuss this decision, please return to your doctor. You should inform your doctor if any of the symptoms described above progress or if you experience complications when patients under 18 years old are taking citalopram. At the same time, the long-term effects of citalopram on safety, growth, maturity, and cognitive and behavioral development in this age group have not yet been demonstrated.

Taking Citalopram cinfa with other medicines

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.

Some medicines can affect the action of others and may cause severe adverse reactions.

Inform your doctor if you are using any of the following medicines:

  • Non-selective monoamine oxidase inhibitors (MAOIs) containing phenelzine, iproniazid, isocarboxazid, nialamide, and tranylcypromine as active substances. If you have taken any of these medicines, you should wait 14 days before starting to take citalopram. After finishing citalopram treatment, you should wait 7 days before taking any of these medicines.
  • Selective reversible MAO-A inhibitors containing moclobemide (used for the treatment of depression).
  • The antibiotic linezolid.
  • Lithium (used for the prophylaxis and treatment of manic-depressive disorder) and tryptophan.
  • Imipramine and desipramine (both used to treat depression).
  • Irreversible MAO-B inhibitors, containing selegiline (used for the treatment of Parkinson's disease); these increase the risk of adverse effects. The dose of selegiline should not exceed 10 mg per day.
  • Metoprolol (used for high blood pressure and/or heart disease); blood levels of metoprolol increase, but no signs of increased effect or adverse effects of metoprolol have been observed.
  • Sumatriptan and similar medicines (used to treat migraines) and tramadol and similar medicines (opioids, used for severe pain) increase the risk of adverse effects, if you have any unusual symptoms using this combination, you should see your doctor.
  • Cimetidine, lansoprazole, and omeprazole (used to treat stomach ulcers), fluconazole (used to treat fungal infections), fluvoxamine (antidepressant), and ticlopidine (used to reduce the risk of stroke). Citalopram blood levels may be increased, but no increased adverse effects of citalopram have been reported.
  • Medicines that affect platelet function, such as some antipsychotics, aspirin (used for pain), non-steroidal anti-inflammatory drugs (used for arthritis); slightly increase the risk of bleeding disorders.
  • St. John's Wort (Hypericum perforatum) (a herbal remedy used for depression); concomitant administration with citalopram may increase the risk of adverse effects.
  • Mefloquine (used to treat malaria), bupropion (used to treat depression), and tramadol (used for severe pain) due to a possible risk of lowering the seizure threshold.
  • Neuroleptics (medicines for schizophrenia, psychosis), due to a possible risk of lowering the seizure threshold, and antidepressants.
  • Class IA and III antiarrhythmics, antipsychotics (e.g. phenothiazine derivatives, pimozide, haloperidol), tricyclic antidepressants, certain antimicrobials (sparfloxacin, moxifloxacin, erythromycin IV, pentamidine, antimalarial drugs particularly halofantrine), certain antihistamines (astemizol, mizolastine).
  • Medicines that lower potassium or magnesium levels in the blood, as this increases the risk of cardiac arrhythmias, which are life-threatening.

Do not take citalopram if you are taking medicines because you already have a disease that alters the heart rhythm or if you are taking medicines that could affect the heart rhythm.

If you have any doubts about this, consult your doctor.

Taking Citalopram cinfa with food, drinks, and alcohol

Citalopram can be taken with or without food (see section 3 “How to take Citalopram cinfa”).

Citalopram has been observed not to increase the effects of alcohol. However, it is recommended to avoid consuming alcohol during treatment with citalopram.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medicine.

Pregnant women should not normally take citalopram, and mothers should not breastfeed their babies while taking this medicine, unless you and your doctor have analyzed the risks and benefits involved.

If you take citalopram during the last 3 months of your pregnancy and until the date of birth, be aware that the following effects may be observed in the newborn baby: difficulty breathing, blue skin, seizures, changes in body temperature, difficulty feeding, vomiting, low blood sugar, muscle stiffness or weakness, intense reflexes, tremors, restlessness, irritability, drowsiness, and difficulty falling asleep. If your newborn baby has any of these symptoms, please contact your doctor immediately.

If you take citalopram in the final stages of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking citalopram to be able to advise you.

Citalopram passes into breast milk in small amounts. There is a risk of effects in the baby. If you are taking citalopram, inform your doctor before starting breastfeeding.

Make sure your midwife and/or doctor are informed that you are being treated with citalopram. During pregnancy, especially in the last 3 months, medicines like citalopram may increase the risk of a serious disease in newborns, called persistent pulmonary hypertension of the newborn (PPHN), in which the baby breathes rapidly and turns blue. These symptoms usually start within the first 24 hours after birth. If they appear in your baby, you should contact your midwife and/or doctor immediately.

Citalopram has been shown to reduce sperm quality in animal models. Theoretically, this effect could affect fertility, but until now, it has not been observed in human fertility.

Driving and operating machinery

During treatment with citalopram, you may feel drowsy or dizzy. Do not drive or operate tools or machines until you know how citalopram affects you.

Citalopram cinfa contains lactose.

This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medicine.

Citalopram cinfa contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially “sodium-free”.

3. How to take Citalopram cinfa

Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

Adults

Depression

The recommended dose is 20 mg per day. If necessary, your doctor may increase this dose up to a maximum of 40 mg per day.

Anxiety disorder

The initial recommended dose is 10 mg per day for the first week before increasing it to 20-30 mg per day. If necessary, your doctor may increase this dose up to a maximum of 40 mg per day.

Obsessive-compulsive disorder (OCD)

The initial recommended dose is 20 mg per day. If necessary, your doctor may increase this dose up to a maximum of 40 mg per day.

Older adults (65 years and older)

In older adults, treatment should be initiated with half the recommended dose, for example 10-20 mg per day.

Generally, older adults should not take more than 20 mg per day.

Patients with special risks

Patients with liver disease should not take more than 20 mg per day.

Use in children and adolescents

Citalopram should not be administered to children or adolescents. For additional information, please see section 2 “What you need to know before starting to take Citalopram cinfa”.

How and when to take Citalopram cinfa

Citalopram is taken once a day as a single daily dose.

Tablets can be taken at any time of the day, regardless of meals. Tablets should be swallowed with a glass of water. Do not chew (they have a bitter taste).

The groove is only for breaking the tablet if it is difficult to swallow whole.

There are other commercial presentations with the same active ingredient that allow administering 10, 30, or 40 mg of citalopram.

Treatment duration

Like other depression, anxiety disorder, and obsessive-compulsive disorder medications, it may take several weeks to find some improvement. Continue taking citalopram even if you do not feel any improvement in your condition.

Never change the medication dose without talking to your doctor first.

The treatment duration is individual, generally at least 6 months. Continue taking the tablets for the recommended time by your doctor. Do not stop taking them unless your doctor tells you to. The underlying disease may persist for a long time, and if you stop treatment too soon, your symptoms may reappear.

Patients with recurrent depressions benefit from continued treatment, sometimes for several years, to prevent the occurrence of new depressive episodes.

If you take more Citalopram Cinfa than you should

If you think you or someone else has taken more citalopram than they should, contact your doctor or pharmacist immediately, go to the nearest hospital emergency department, or call the Toxicology Information Service, phone 915.620.420, indicating the medication and the amount taken.

Do this even if you do not observe any discomfort or signs of intoxication. Bring the citalopram packaging with you if you visit the doctor or hospital.

Some symptoms of an overdose may include irregular heartbeats with a risk to life, seizures, changes in heart rhythm, drowsiness, coma, vomiting, tremors, increased or decreased blood pressure, nausea (feeling dizzy), serotonin syndrome (see section 4. “Possible side effects”), agitation, dizziness, dilated pupils, sweating, blue skin, hyperventilation (increased respiratory rate).

If you forgot to take Citalopram cinfa

If you forgot to take a dose, take the next dose at the usual time. Do not take a double dose to compensate for the missed doses.

If you interrupt the treatment with Citalopram cinfa

Do not stop taking citalopram until your doctor tells you to. When you have completed your treatment period, it is generally recommended to gradually reduce the citalopram dose over several weeks.

Abrupt withdrawal of the medication may cause some mild or transient disturbances, such as dizziness, tingling sensation, sleep disturbances (intense dreams, nightmares, inability to sleep), anxiety, headache, dizziness (nausea), vomiting, sweating, restlessness or agitation, tremors, feeling of confusion or disorientation, feelings of emotion or irritability, diarrhea (loose stools), visual disturbances, rapid pulse or palpitations.

When you have finished your treatment period, it is generally recommended to gradually reduce the citalopram dose over a couple of weeks instead of stopping it abruptly.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

Side effects usually disappear after a few weeks of treatment. Please note that many of the effects can also be symptoms of your illness and will improve when you start feeling better.

Some patients have reported the followingserious side effects.

If you have any of the following symptoms, stop taking citalopram and see your doctor immediately.

  • Fever, agitation, confusion, tremors, and sudden muscle contractions; they may be signs of a rare condition called serotonin syndrome, which has been reported with the combined use of antidepressants.
  • If you notice swelling of the skin, tongue, lips, or face, or have difficulty breathing or swallowing (allergic reaction).
  • Unusual bleeding, including gastrointestinal bleeding.

Rare but serious side effects(may affect up to 1 in 1,000 patients):

If you have any of the following symptoms, stop taking citalopram and see your doctor immediately.

  • Hyponatremia: low sodium levels in the blood that can cause fatigue, confusion, and muscle cramps.
  • Fast or irregular heartbeats or a feeling of dizziness, which may be symptoms of a serious heart condition called Torsade de Pointes.

The following side effects are generally mild and usually disappear after a few days of treatment. Please be aware that several of the effects mentioned below can be symptoms of your illness and will improve when you start feeling better.

If side effects are bothersome or last longer than a few days, consult your doctor.

Dry mouth increases the risk of tooth decay. Therefore, you should brush your teeth more frequently than usual.

Very common side effects(may affect more than 1 in 10 patients):

  • Tendency to sleep.
  • Difficulty sleeping.
  • Increased sweating.
  • Dry mouth.
  • Nausea (feeling dizzy).
  • Headache

Common side effects(may affect up to 1 in 10 patients):

  • Loss of appetite.
  • Agitation.
  • Decreased sexual behavior.
  • Anxiety.
  • Nervousness.
  • Confusional state.
  • Abnormal dreams.
  • Tremors.
  • Tickling or numbness in hands or feet.
  • Dizziness.
  • Attention disturbance.
  • Tinnitus (ringing in the ears).
  • Yawning.
  • Diarrhea.
  • Vomiting.
  • Constipation.
  • Rash.
  • Muscle and joint pain.
  • Men may experience problems with ejaculation and erection.
  • Women may experience difficulty reaching orgasm.
  • Fatigue.
  • Itching skin.
  • Weight loss.

Uncommon side effects(may affect up to 1 in 100 patients):

  • Bleeding disorders (easy bruising).
  • Increased appetite.
  • Aggression.
  • Depersonalization.
  • Hallucinations.
  • Mania.
  • Loss of consciousness.
  • Dilated pupils.
  • Fast heartbeats.
  • Slow heartbeats.
  • Hives.
  • Hair loss.
  • Rash.
  • Photophobia.
  • Urination difficulties.
  • Excessive menstrual bleeding.
  • Swelling of arms and legs.
  • Weight gain.

Rare(may affect up to 1 in 1,000 patients):

  • Seizures.
  • Involuntary movements.
  • Taste disturbances.
  • Bleeding.
  • Hepatitis.
  • Fever.

Frequency not known(cannot be estimated from available data):

  • Thoughts of self-harm or suicidal thoughts, see also the "Warnings and precautions" section.
  • Reduction of platelets in the blood, which increases the risk of bleeding or bruising (hematoma).
  • Hypersensitivity (rash).
  • Severe allergic reaction that causes difficulty breathing or dizziness.
  • Increased urine output.
  • Hypokalemia: low potassium levels in the blood that can cause muscle weakness, cramps, or irregular heart rhythm.
  • Panic attack.
  • Clicking of teeth.
  • Restlessness.
  • Abnormal muscle movements or stiffness.
  • Akathisia (involuntary muscle movements).
  • Visual disturbances.
  • Low blood pressure.
  • Nasal bleeding.
  • Bleeding disorders, including skin and mucous membrane bleeding (ecchymosis).
  • Heavy vaginal bleeding shortly after delivery (postpartum hemorrhage), see "Pregnancy, lactation, and fertility" in section 2 for more information.
  • Sudden skin or mucous membrane swelling.
  • Painful erections.
  • Increased prolactin levels in the blood.
  • Milk production in men and women who are not breastfeeding.
  • Irregular menstrual periods.
  • Altered liver function tests.
  • Orthostatic hypotension (significant drop in blood pressure when standing up).
  • A higher risk of bone fractures has been observed in patients treated with this type of medication.
  • Abnormal heart rhythm.

If you experience side effects, consult your doctor or pharmacist, even if they are side effects that do not appear in this leaflet.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Conservation of Citalopram cinfa

Keep this medication out of the sight and reach of children.

Do not store at a temperature above 30°C.

Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.

Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and themedicines that you no longer need at theSIGREPoint of the pharmacy. If in doubt, ask yourpharmacist how to dispose of the packaging and the medicines that you no longer need.By doing so, you will help protect the environment.

6. Contents of the packaging and additional information

Citalopram cinfa Composition

  • The active ingredient is citalopram. Each tablet contains 20 mg of citalopram (in the form of citalopram hydrobromide).
  • The other components are:
    • Tablet core: cornstarch, lactose monohydrate, microcrystalline cellulose, povidone, sodium lauryl sulfate, sodium croscarmellose, and magnesium stearate.
    • Tablet coating: Opadry Y (hypromellose (E-464), macrogol 400, and titanium dioxide (E-171)).

Appearance of the product and contents of the packaging

Citalopram cinfa is presented in the form of white, cylindrical, biconvex, scored tablets on one side and marked with the code “C20” on the other. Each package contains 14, 28, 56, or 500 (clinical package) tablets.

Only some package sizes may be marketed.

Marketing authorization holder and responsible manufacturer

Marketing authorization holder

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) - Spain

Responsible manufacturer

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta

31620 Huarte (Navarra) - Spain

or

Cyndea Pharma S.L

Polígono Industrial Emiliano Revilla Sanz

Avenida de Ágreda, 31

42110 Ólvega, Soria - Spain

Last review date of this leaflet: February 2025

For detailed information about this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/

You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/67804/P_67804.html

QR code to: https://cima.aemps.es/cima/dochtml/p/67804/P_67804.html

Країна реєстрації
Активна речовина
Потрібен рецепт
Так
Виробник
Склад
Laurilsulfato de sodio (0,63 mg mg), Croscarmelosa sodica (2,50 mg mg), Lactosa hidratada (23,72 mg mg)
Информация носит справочный характер и не является медицинской рекомендацией. Перед приёмом любых препаратов проконсультируйтесь с врачом. Oladoctor не несёт ответственности за медицинские решения, принятые на основе этого контента.

Поговоріть з лікарем онлайн

Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.

5.01 відгук
Doctor

Anna Moret

Dermatology18 років досвіду

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for: • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis • Pediatric skin problems — from newborns to adolescents • Sexually transmitted infections (STIs) and dermatovenereology • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments • Skin allergies and hypersensitivity reactions • Mole checks, lesion evaluation, and skin cancer screening • Skincare advice and personalised cosmeceutical routines

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

Записатися на онлайн-консультацію
5.01 відгук
Doctor

Alina Tsurkan

Family Medicine12 років досвіду

Dr. Alina Tsurkan is a licensed family medicine doctor based in Portugal. She provides personalised primary care for both adults and children, helping patients manage a wide range of everyday health concerns with professionalism and attention to detail.

Dr. Tsurkan diagnoses and treats common conditions such as: • Respiratory infections (cold, flu, bronchitis, pneumonia) • Eye conditions: conjunctivitis (infectious and allergic) • ENT problems (sinusitis, ear infections, tonsillitis) • Digestive issues including gastritis, acid reflux, and IBS • Urinary tract infections and other frequent infections • Chronic conditions such as high blood pressure, diabetes, and thyroid disorders • Headaches and migraines

In addition to symptom-based care, Dr. Tsurkan focuses on prevention and early detection. She offers regular health check-ups, follow-up care, and medical prescriptions tailored to each patient’s needs.

With a comprehensive and caring approach, Dr. Tsurkan supports patients at every stage of life — from acute illnesses to long-term health management.

Записатися на онлайн-консультацію
5.09 відгуків
Doctor

Andrei Popov

General Medicine6 років досвіду

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including: • Chronic pain lasting more than 3 months • Migraines and recurring headaches • Neck, back, lower back, and joint pain • Post-traumatic pain following injury or surgery • Nerve-related pain, fibromyalgia, and neuralgia In addition to pain management, Dr. Popov helps patients with: • Respiratory infections (colds, bronchitis, pneumonia) • High blood pressure and metabolic conditions such as diabetes • Preventive care and routine health check-ups

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

Записатися на онлайн-консультацію
5.01 відгук
Doctor

Yevgen Yakovenko

General Surgery11 років досвіду

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain, with a diverse clinical background in general and pediatric surgery, internal medicine, and pain management. With a strong focus on both practice and research, he provides comprehensive medical consultations for adults and children, covering both surgical and therapeutic needs.

Dr. Yakovenko offers expert care in the following areas: • Diagnosis and treatment of acute and chronic pain • Pre- and postoperative care, including risk assessment and follow-up • Surgical conditions such as hernias, gallbladder disease, and appendicitis • Pediatric surgery consultations, including congenital conditions and minor procedures • Trauma care: fractures, soft tissue injuries, and wound management • Oncological surgery consultation and post-treatment care • Cardiovascular and respiratory conditions (internal medicine) • Orthopedic concerns and post-trauma rehabilitation • Radiological interpretation for surgical planning

In addition to his clinical work, Dr. Yakovenko actively participates in medical research and international collaboration. He is a member of the German Surgeons Association (BDC), affiliated with the General Practitioners Association of Las Palmas, and works with the German Consulate in the Canary Islands. He regularly attends international medical conferences and has authored scientific publications.

With over a decade of multidisciplinary experience, Dr. Yakovenko delivers precise, evidence-based care tailored to each patient’s needs.

Записатися на онлайн-консультацію
Переглянути всіх лікарів

Слідкуйте за новинами та заощаджуйте на послугах

Поради лікарів, оновлення платформи та знижки для підписників.

Слідкуйте за нами в соцмережах